COM:ANIKA
Anika Therapeutics
- Stock
Last Close
17.43
22/11 21:00
Market Cap
389.26M
Beta: -
Volume Today
61.03K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 105.59M - | 93.00M 11.93% | 103.38M 11.16% | 113.42M 9.71% | 105.56M 6.93% | 114.61M 8.58% | 130.46M 13.83% | 147.79M 13.29% | 156.24M 5.71% | 166.66M 6.67% | |
cost of revenue | 20.93M - | 21.05M 0.59% | 24.03M 14.13% | 27.36M 13.89% | 31.28M 14.31% | 28.75M 8.10% | 61.43M 113.70% | 64.85M 5.57% | 62.66M 3.38% | 63.57M 1.46% | |
gross profit | 84.66M - | 71.95M 15.02% | 79.35M 10.29% | 86.06M 8.45% | 74.28M 13.69% | 85.86M 15.60% | 69.03M 19.61% | 82.94M 20.16% | 93.58M 12.82% | 103.09M 10.16% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 15.07M - | 14.82M 1.65% | 18.01M 21.50% | 21.54M 19.58% | 34.34M 59.41% | ||||||
selling general and administrative expenses | 15.07M - | 14.82M 1.65% | 18.01M 21.50% | 21.54M 19.58% | 34.34M 59.41% | 34.95M 1.79% | 60.06M 71.85% | 74.10M 23.36% | 84.79M 14.44% | 95.85M 13.04% | |
research and development expenses | 8.14M - | 8.99M 10.35% | 10.73M 19.42% | 18.79M 75.06% | 18.19M 3.18% | 16.66M 8.38% | 23.43M 40.60% | 27.33M 16.63% | 28.18M 3.13% | 32.69M 16.00% | |
other expenses | |||||||||||
cost and expenses | 44.15M - | 44.87M 1.62% | 52.77M 17.62% | 67.69M 28.27% | 83.81M 23.81% | 80.36M 4.11% | 144.93M 80.34% | 166.27M 14.73% | 175.64M 5.63% | 192.11M 9.38% | |
operating expenses | 23.22M - | 23.81M 2.56% | 28.75M 20.72% | 40.33M 40.29% | 52.53M 30.25% | 51.62M 1.73% | 83.49M 61.76% | 101.42M 21.47% | 112.98M 11.39% | 128.54M 13.77% | |
interest expense | -58.14K - | -120K 106.41% | -263K 119.17% | -473K 79.85% | -1.46M 208.25% | -302K - | -188K 37.75% | 654K 447.87% | 2.31M 253.52% | ||
ebitda | 61.45M - | 48.13M 21.67% | 50.61M 5.14% | 45.73M 9.64% | 21.75M 52.44% | 34.25M 57.47% | -614K 101.79% | -39.58M 6,345.44% | -19.40M 50.98% | -11.21M 42.19% | |
operating income | 61.45M - | 48.13M 21.67% | 50.61M 5.14% | 45.73M 9.64% | 21.75M 52.44% | 34.25M 57.47% | -14.47M 142.24% | -18.48M 27.73% | -19.40M 4.98% | -25.45M 31.18% | |
depreciation and amortization | 4.71M - | 3.77M 19.78% | 3.73M 1.09% | 4.29M 14.89% | 5.91M 37.76% | 5.99M 1.37% | 13.85M 131.25% | -21.09M 252.27% | 14.49M 168.68% | 14.23M 1.75% | |
total other income expenses net | 58.14K - | 120K 106.41% | 263K 119.17% | 473K 79.85% | 1.46M 208.25% | 1.87M 28.46% | -14.16M 855.79% | 20.91M 247.69% | 654K 96.87% | -59.88M 9,255.66% | |
income before tax | 61.51M - | 48.25M 21.54% | 50.87M 5.42% | 46.20M 9.18% | 23.21M 49.77% | 36.12M 55.65% | -28.62M 179.24% | 2.43M 108.48% | -18.75M 872.39% | -85.33M 355.17% | |
income tax expense | 23.19M - | 17.50M 24.54% | 18.32M 4.73% | 14.39M 21.49% | 4.49M 68.82% | 8.93M 99.06% | -4.64M 151.99% | -1.71M 63.23% | -3.89M 127.71% | -2.66M 31.57% | |
net income | 38.32M - | 30.76M 19.73% | 32.55M 5.82% | 31.82M 2.25% | 18.72M 41.16% | 27.19M 45.25% | -23.98M 188.19% | 4.13M 117.24% | -14.86M 459.43% | -82.67M 456.34% | |
weighted average shs out | 14.68M - | 14.93M 1.74% | 14.68M 1.69% | 14.57M 0.73% | 14.44M 0.91% | 14.12M 2.22% | 14.22M 0.72% | 14.40M 1.26% | 14.56M 1.11% | 14.66M 0.65% | |
weighted average shs out dil | 15.27M - | 15.32M 0.34% | 15.12M 1.34% | 15.07M 0.32% | 14.69M 2.52% | 14.37M 2.14% | 14.22M 1.06% | 14.63M 2.90% | 14.56M 0.50% | 14.66M 0.65% | |
eps | 2.61 - | 2.06 21.07% | 2.22 7.77% | 2.18 1.80% | 1.30 40.37% | 1.93 48.46% | -1.69 187.56% | 0.29 117.16% | -1.02 451.72% | -5.64 452.94% | |
epsdiluted | 2.51 - | 2.01 19.92% | 2.15 6.97% | 2.11 1.86% | 1.27 39.81% | 1.89 48.82% | -1.69 189.42% | 0.28 116.57% | -1.02 464.29% | -5.64 452.94% |
All numbers in USD (except ratios and percentages)